[HTML][HTML] Use of ivermectin is associated with lower mortality in hospitalized patients with coronavirus disease 2019: the ivermectin in COVID nineteen study

JC Rajter, MS Sherman, N Fatteh, F Vogel, J Sacks… - Chest, 2021 - Elsevier
Background Ivermectin was shown to inhibit severe acute respiratory syndrome coronavirus
2 replication in vitro, which has led to off-label use, but clinical efficacy has not been …

ICON (Ivermectin in COvid Nineteen) study: use of ivermectin is associated with lower mortality in hospitalized patients with COVID19

JC Rajter, MS Sherman, N Fatteh, F Vogel, J Sacks… - MedRxiv, 2020 - medrxiv.org
Importance No therapy to date has been shown to improve survival for patients infected with
SARS-CoV-2. Ivermectin has been shown to inhibit the replication of SARS-CoV-2 in vitro …

Standard equations are not accurate in assessing resting energy expenditure in patients with amyotrophic lateral sclerosis

MS Sherman, A Pillai, A Jackson… - Journal of Parenteral …, 2004 - Wiley Online Library
Objective: To assess the utility of standard equations for calculating caloric requirements in
patients with amyotrophic lateral sclerosis (ALS). Background: Malnutrition substantially …

Guidelines and realities of asthma management: the Philadelphia story

DM Lang, MS Sherman… - Archives of Internal …, 1997 - jamanetwork.com
Background: Guidelines from the National Heart, Lung, and Blood Institute, Bethesda, Md,
have encouraged more frequent use of inhaled steroids in asthma management. Objectives: …

Hyperalimentation-induced cholestasis: increased incidence and severity in premature infants

GR Pereira, MS Sherman, J DiGiacomo… - American Journal of …, 1981 - jamanetwork.com
• Two hundred sixty-seven neonates who received parenteral nutrition were monitored for
signs of liver dysfunction. Cholestatic jaundice occurred in 23 infants, with a higher incidence …

Review of respiratory care of the patient with amyotrophic lateral sclerosis

MS Sherman, HL Paz - Respiration, 1994 - karger.com
Respiratory failure is the leading cause of death in patients with amyotrophic lateral sclerosis
(ALS). We review the physiology of respiratory compromise in ALS and techniques of …

Pulmonary dysfunction and reduced exercise capacity in patients with myelomeningocele

MS Sherman, JM Kaplan, S Effgen, D Campbell… - The Journal of …, 1997 - Elsevier
OBJECTIVE: To evaluate pulmonary function and exercise capacity in children with
myelomeningocele. STUDY DESIGN: Prospective evaluation in a randomly selected cohort of 12 …

A bronchodilator action of glucagon

MS Sherman, EJ Lazar, P Eichacker - Journal of allergy and clinical …, 1988 - Elsevier
We evaluated the effect of glucagon on eight patients with asthma. After withholding
bronchodilators for 12 hours, patients received either 2 units of intravenous glucagon or 2 ml of …

Health values in adolescents with or without inflammatory bowel disease

SY Michael, MT Britto, SN Sherman, MS Moyer… - The Journal of …, 2009 - Elsevier
OBJECTIVE: To examine for differences in and predictors of health value/utility scores in
adolescents with or without inflammatory bowel disease (IBD). STUDY DESIGN: Adolescents …

Reproduction and pregnancy in transplant recipients: current practices

…, N Tolkoff-Rubin, MS Sherman… - Progress in …, 2006 - journals.sagepub.com
Many transplant physicians are faced with questions from their patients about the safety and
long-term consequences of pregnancy following transplantation. To better understand how …